Genprex Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Genprex Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Texas
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GNPX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001595248
- EIN
- 90-0772347
Board of directors
-
Brent M. Longnecker · DirectorSince 2023
-
John Rodney Varner · Director · Chairman, President and CEOSince 2023
-
Ryan M. Confer · Director · President, CEO and CFOSince 2024
-
Toscano Jose Antonio Moreno · DirectorSince 2023
-
William R. Wilson Jr. · DirectorSince 2023
Chief executives
John Rodney Varner
· President & CEO
Dates unknown
Ryan M. Confer
· President, CEO and CFO
Dates unknown
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $22
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Brent M. Longnecker Director | Open-market sale | −8 | $1.23 | $10 |
| Apr 14, 2026 | Brent M. Longnecker Director | Open-market sale | −10 | $1.23 | $12 |
| Feb 27, 2026 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −7,168 | $2.00 | $14,336 |
| Feb 27, 2026 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −9,330 | $2.00 | $18,660 |
| Dec 22, 2025 | Toscano Jose Antonio Moreno Director | Grant or award | +9,000 | — | — |
| Dec 22, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Grant or award | +28,500 | — | — |
| Dec 22, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Grant or award | +45,000 | — | — |
| Dec 22, 2025 | Brent M. Longnecker Director | Grant or award | +9,000 | — | — |
| Dec 22, 2025 | William R. Wilson Jr. Director | Grant or award | +9,000 | — | — |
| Jun 30, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −4,500 | $0.23 | $1,035 |
| Jun 30, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −5,775 | $0.23 | $1,328 |
| Feb 18, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −585 | $0.41 | $240 |
| Feb 18, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −395 | $0.41 | $162 |
| Dec 5, 2024 | Toscano Jose Antonio Moreno Director | Grant or award | +4,750 | — | — |
| Dec 5, 2024 | William R. Wilson Jr. Director | Grant or award | +4,750 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.